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Background: Patients with diabetes are at increased risk for depression, compounding the burden of disease.
When comorbid with diabetes, depression leads to poorer health outcomes and often complicates diabetes
self-management. Unfortunately, treatment options for these complex patients are limited and comprehensive
services are rarely available for patients in rural settings.
Methods: A small open trial was conducted to test the acceptability, feasibility and preliminary outcomes of a
telephone-delivered coaching intervention for rural-dwelling older adults with uncontrolled diabetes and comorbid,
clinically significant depressive symptoms. A total of eight older adults were enrolled in Healthy Outcomes through
Patient Empowerment (HOPE), a 10-session (12-week), telephone-based coaching intervention. Primary study
constructs included measures of diabetes control (Hemoglobin [Hb] A1c), depressive symptoms (Patient Health
Questionnaire-9 [PHQ-9]), and diabetes-related distress (Problem Areas in Diabetes Scale [PAID]). Assessments were
conducted at baseline, post-intervention, and 6-month follow-up. Acceptability and feasibility were evaluated using
patient surveys, focused exit interviews, and session attendance data.
Results: Clinically significant improvements were realized post-intervention and at 6-month follow-up for outcomes
related to diabetes and depression. Effect sizes using Cohen's d were determined post-intervention and at 6-month
follow-up, respectively, for HbA1c (d=0.36; d=0.28), PHQ-9 (d=1.48; d=1.67, and PAID (d=1.50; d=1.06) scores. Among
study participants, HbA1c improved from baseline by a mean (M) of 1.13 (SD=1.70) post-intervention and M=0.84
(SD=1.62) at 6 months. Depression scores, measured by the PHQ-9, improved from baseline by M=5.14 (SD=2.27)
post-intervention and M=7.03 (SD=4.43) at 6-month follow-up. PAID scores also improved by M=17.68 (SD=10.7)
post-intervention and M=20.42 (SD=20.66) from baseline to 6-month follow-up. Case examples are provided for
additional context and to more fully articulate salient intervention concepts.
Conclusion: Although preliminary, data from this small open trial suggest that HOPE holds the potential to
improve both physical (diabetes) and emotional (diabetes distress, depression) health outcomes and that changes
can be maintained over a 6-month time period. As envisioned by the authors, HOPE may function as an extension
of traditional primary care for rural-dwelling older adults with multiple comorbidities. A future randomized clinical
trial will test HOPE’s broader effectiveness with rural-dwelling older adults.
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Diabetes mellitus is a chronic disease affecting 8.3% of
the US population, with this percentage sharply increas-
ing for older adults (15-20%) and often leading to ser-
ious medical complications and high healthcare costs
[1]. Patients with diabetes are at increased risk for de-
pression, compounding the burden of disease [2]. When
comorbid with diabetes, depression leads to poorer
health outcomes and often complicates diabetes self-
management [2-5]. Although multidisciplinary treat-
ments for diabetes and depression are possible, access to
such care is highly limited, especially for rural-dwelling
older individuals [6,7]. It is far more common for
patients with complex diabetes and depression to receive
inadequate or uncoordinated treatment for these condi-
tions [8-10].
Prior clinical trials for diabetes and depression suggest
limited reach and modest effectiveness. Intensive pro-
grams involving depression medications and behavioral
counseling (stepped care management, collaborative
care) improve clinically significant depressive symptoms
and quality of life in primary care patients with depres-
sion but not diabetes self-management or clinical out-
comes [11]. Coordinated and stepped care interventions
for comorbid cases appear to neglect diabetes care by
relying on intervention models specific to depression
management and directing intervention practices pri-
marily toward depressive symptoms without translation
to diabetes self-care [12,13]. A few studies currently
under way utilize cognitive behavioral therapy, but these
are again focused on either depression [14] or diabetes
self-care [15] and not on behavior change techniques
that can be applied to both conditions. Thus, behavioral
strategies that activate patients to perform health beha-
viors for both diabetes and depression hold the potential
to improve both the emotional and physical health diffi-
culties of these medically complex patients.
The current study used a small open trial format to
examine the acceptability, feasibility and preliminary
outcomes of a telephone-delivered behavioral coaching
intervention for rural-dwelling older adults with uncon-
trolled diabetes and comorbid, clinically significant de-
pressive symptoms. The intervention used a flexible
patient-centered approach to treatment, targeting phys-
ical and emotional health issues simultaneously.Methods
Procedure
All procedures for the HOPE trial were approved by the
Baylor College of Medicine Institutional Review Board
(IRB) and the Michael E. DeBakey Veterans Affairs (VA)
Medical Center Office of Research and Development,
Houston, TX.Participants
HOPE recruitment sought to engage rural-living older
adults with uncontrolled diabetes and comorbid, clinic-
ally elevated depressive symptoms. Data from a VA pa-
tient registry was extracted to identify rural-dwelling
individuals with uncontrolled type 2 diabetes mellitus, as
indicated by average glycated hemoglobin (HbA1c) of 7.5
or greater and no single HbA1c marker below 7.0 over
the past year. Individuals who met these inclusionary cri-
teria were mailed an opt-out letter describing the HOPE
Program. One week after the mail-out, a member of the
project team called potential participants to ascertain
their interest in participating. Interested individuals com-
pleted a short screening assessment, including a six-item
cognitive screener, a three-item mental health screener,
and the Patient Health Questionnaire-2 (PHQ-2), a vali-
dated, short version of the PHQ-9, used to screen for de-
pressive symptoms [16]. A binder with detailed study
information, including informed consent and print-based
aids for telephone assessments, was sent to each person
who met initial screening criteria. A project team mem-
ber then called qualifying patients to review consent
materials and obtain audio-taped consent prior to con-
ducting a baseline assessment interview, which included
a demographic questionnaire and the PHQ-9. Patients
satisfying baseline depression screening requirements
(i.e., PHQ-9 score of 10 or greater) were enrolled in the
HOPE program, administered the remaining baseline as-
sessment measures, scheduled for lab work (i.e., HbA1C
test) at their local primary care site, and mailed a HOPE
program intervention workbook.
Intervention
The HOPE intervention consisted of ten 30–45 minute
sessions delivered by telephone over a 12-week period.
The overall objective of HOPE was to assist participants
to improve their ability to self-manage their physical and
emotional health. HOPE coaches (described below)
sought to assist participants to prioritize their self-care
needs, and to identify and resolve barriers to effective
self-care. Participants learned and practiced skills that
would help them reach the goals and action plans they
set for themselves to improve their self-care [17]. While
prior clinical interventions have targeted either physical
or emotional issues, HOPE extends these efforts by
addressing both dimensions simultaneously [18].
HOPE uses a structured patient workbook to guide
participants and coaches. The workbook, modeled using
prior work from this group [19,20] used a module-based
approach where participants and coaches selected treat-
ment goals and self-management skills that met the indi-
vidual needs of the patient. The workbook was
structured to facilitate behavioral change through collab-
orative goal-setting and action planning across physical
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ture, allowing coaches to use structured information pre-
sented in physical and emotional health modules to
stimulate conversation around issues of personal salience
to patients, to educate patients on these issues and to
build skills necessary to practice goals and action plans.
Goal-setting and action planning components (e.g.,
worksheets to stimulate collaborative construction of
high-quality goals and action plans) were incorporated
throughout physical and emotional heath modules.
These components were previously employed in a ran-
domized clinical trial demonstrating that collaborative
goal-setting in group diabetes clinics is associated with
improved diabetes control [20]. In the HOPE interven-
tion, collaborative goal setting and action planning
reflected an iterative process whereby coaches assisted
patients to set personally meaningful goals and action
plans to meet their goals. Coaches continuously assessed
goal attainment with patients, focusing on barriers and
collaborative problem-solving to negate these barriers.
The coaching model for the HOPE Program was based
on the 5 As Model for coping with chronic illness [21,22].
Guided by the 5 As (i.e., Assess, Advise, Agree, Assist, Ar-
range), intervention coaches assisted participants in select-
ing and refining physical and emotional health goals and
in developing action plans to meet their goals.
HOPE sessions and modules
Table 1 describes the content of session modules and
the overall intervention structure by session. HOPE was
structured around core concepts but also included a
modular component that allowed coaches and patients
to focus on physical and mental health difficulties of per-
sonal salience to the participant. The goal of this
modular-based approach was to advance patient involve-
ment and empowerment through active participation in
the treatment process.
Core sessions (sessions 1 and 2)
The first two HOPE sessions educated participants about
the importance of holistic diabetes self-care, emphasiz-
ing both physical health monitoring and emotional well-
being as complementary dimensions of maintaining
overall health. Session 1 introduced participants to the
HOPE intervention and focused on rapport building by
assessing feelings about diabetes and physical and emo-
tional health challenges. In Session 2, participants
learned the principles of effective goal setting and action
planning and begun to apply these theoretical principles
to their own situations.
Elective sessions (sessions 3 to 8)
HOPE provided participants with the flexibility and auton-
omy to select from six elective physical and emotionalhealth modules. Elective modules included: Managing
Your Medications, Using Thoughts to Improve Wellness,
Eating a Healthy Diet, Increasing Pleasant Activities,
Getting Fit, and Learning How to Relax (see Table 1).
Each module incorporated skill-building techniques, di-
dactic learning, and interactive exercises designed to fa-
cilitate goal setting and action planning. Participants
chose the order in which modules were discussed, based
on their preferences and self-care needs. Participants
could spend two or more sessions focused on a particu-
lar module, either to build on a successful attempt at
implementing an action plan, or to revise an action plan
he/she was unable to practice because of unforeseen
obstacles.Follow-up sessions (sessions 9 and 10)
In Session 9, coach/participant dyads reviewed all goals
developed in prior sessions and made final action-plan
adjustments, as necessary. Session 10 focused on main-
taining changes post-treatment.HOPE coaches (providers)
Given the limited availability of mental health providers
in the current medical care environment, HOPE sought
to demonstrate the appropriateness of using non-expert
mental health coaches. Coaches were recruited from a
variety of disciplines and training levels including a clin-
ical psychology graduate intern, a developmental psych-
ology postdoctoral fellow, a doctoral student in public
health, and a post-bachelors psychology student. A large
body of literature supports the role of paraprofessionals,
community health workers, and peers in the delivery of
self-management coaching [23-25]. While none of the
coaches in the current study had focused training in dia-
betes care, and only one coach (psychology intern) had
experience treating depression, all coaches received
structured training and follow-up assessment by quali-
fied clinicians.
Coaches also interfaced with primary care providers
and the broader clinical care setting using the VA’s elec-
tronic medical records (EMR) system. Coaches accessed
clinical patient information from the EMR to review past
medical history and identify ongoing treatment plans
from the primary care team in order to set coordinated
clinical care goals and action plans that enabled the
established treatment plan. Coaches then used standar-
dized note templates to inform PCPs about their patients’
goals and action plans. Additionally, coaches encouraged
patients to communicate any further concerns to their
PCPs by assisting them to set goals and action plans
around doctor-patient communication. In essence,
HOPE coaches functioned as clinician-extenders rather
than an alternative or auxiliary provider.
Table 1 HOPE intervention session structure and module content
Session# Week Session Content Session Goals
Core Sessions
Session 1 1 Getting to Know HOPE and Your Coach
•General introduction to the HOPE Program •To build rapport between participant/coach
•Outline of program structure and module content •To encourage open discussion
•Definition of roles/expectations of participant and
coach are defined
•To customize a program to participants’ needs
Session 2 2 Setting Goals and Making Action Plans
• Introduction to the concept of goal setting and
action planning
• For participant to have a foundational understanding
of goal setting/action planning
• 3 rules to follow in developing a high-quality goal • To make first attempt at setting a high -quality goal
• Action Plan Checklist
Elective Sessions
Module A: Managing Your Medications
• Knowing Your Medications • For participant to better understand medication
outcomes (benefits vs. side-effects)
• Choosing the Right Medication for You • To build skill: improve communication with
PCP/healthcare team
• Keeping a Schedule for Taking Your Medications • To set/adjust a medication-adherence goal
Module B: Using Thoughts to Improve Wellness
• Recognizing How Thoughts Affect Mood and
Behaviors
• For participant to understand the impact thoughts have
on feelings and actions
• Using Coping Statements to Improve Wellness • To build skill: coping, alternative thinking
• Increasing Positive Thinking/Decreasing Negative
Thinking
• To set/adjust a goal for practicing thought-
monitoring strategies
Module C: Eating a Healthy Diet
• Controlling Carbohydrate Intake • To improve participant’s knowledge of nutrition and
dietary recommendations
• Increasing Fruit And Vegetable Intake • To build skill: balanced food-group servings, portion control,
healthy food substitutions
• Reducing Unhealthy Fat Intake
• Limiting Portion Sizes • To set/adjust a healthy diet goal
Sessions 3-8 3-8 Module D: Increasing Pleasant Activities
• Recognizing How Behaviors Affect Thoughts
and Moods
• For participant to understand the impact actions can have
on thoughts and feelings
• Identifying Meaningful Activities • To build skill: resuming or beginning new activities of interest
• Engaging In Pleasant Activities and Being Active • To set/adjust a behavioral activation goal
Module E: Getting Fit
• Improving Endurance Through Cardiovascular Exercise • To educate participant about recommended exercise guidelines
• Improving Flexibility Through Stretching
• Improving Strength and Muscle Tone Through
Strength Training
• To set/adjust a fitness goal, considering participant’s
physical limitations
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Table 1 HOPE intervention session structure and module content (Continued)
Module F: Learning How to Relax
• Understanding What Stress, Worry, and Anxiety Are • To identify stressors that impact health
• How to Use Deep Breathing to Reduce Stress
and Tension
• To build skill: practicing deep breathing and/or
imagery exercises
• How to Use Imagery to Reduce Stress and Tension • To set/adjust a goal for incorporating relaxation techniques
into participant’s daily routine
Follow-Up Sessions
Session 9 10 Adjusting Your Action Plans and Overcoming Obstacles
• Review all previous goals and assess goal progress • For participant to reflect on accomplishments realized through
the HOPE Program
• Discussion of remaining barriers/obstacles to goal
success and identification of strategies for
overcoming them
• To build skill: overcoming barriers/obstacles
• To make final adjustments to Action Plans
Session 10 12 Managing Your Resources and Final Discussions
• Final discussions: • For participant to reflect on diabetes-care skills acquired in HOPE
• Diabetes ABCs • To prepare participant to continue goal development on
his/her own, following HOPE
• Resources/support system • For participant to be satisfied with program outcomes and
committed to achieving long-term health goals
• Monitoring Action Plans/tracking goal progress
• Closing remarks
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Coaches were trained and provided with ongoing support
for the intervention, structured around the HOPE work-
book and larger intervention materials. All coaches
received initial and ongoing training (and monitoring of
cases) in the HOPE procedures via weekly group and indi-
vidual supervision lead by the intervention’s dual principal
investigators, a medical geriatrician (Naik) proficient in
primary care of diabetes and a licensed clinical psycholo-
gist (Cully) who specializes in treatment of mental disor-
ders and comorbid chronic disease. During supervision
meetings, coaches would review patients’ progress and ad-
dress challenges related to intervention concepts and use.
Coaches also learned from their peers through discussion
of issues that commonly emerged across patients (e.g., re-
luctance to address medication management), including
the generation of potential solutions that could be used in
subsequent sessions.
In accordance with standardized clinical and research
protocols, coaches were specifically trained to respond
to crisis situations should a patient present with suicidal
ideation/intent or notable decompensation in their phys-
ical or emotional health. A suicide protocol approved by
the IRB included steps to be followed by a coach should
a patient report suicidal ideation or other clinical crisis
information. This protocol included a cascade list of
licensed mental health and medical providers to be con-
tacted immediately by the coach in the event of a high-
risk situation. Licensed providers with hospital privileges
would follow up by calling the patient, assessing theiremotional and physical health needs, and responding
with appropriate care recommendations.
Measures
All study measures were collected by a trained inter-
viewer who remained blind to the intervention practices
of the open trial.
Glycated Hemoglobin (HbA1c)
HbA1c is a form of hemoglobin measured in lab testing
to evaluate an individual’s average percentage of blood
glucose concentration over a 3-month period. HbA1C is
the gold standard for evaluation of diabetes control, as
defined by The American Diabetes Association’s recom-
mendation of HbA1c of 7% or less [26].
Depression
The PHQ-9 is a well-validated assessment of depressive-
symptom severity and is widely used within the VA [26].
Test-retest reliability of this measure demonstrates its
diagnostic utility and capacity to measure significant
change (sensitivity to change) in clinical settings [27,28].
Nine items determine the presence and degree of all
Diagnostic and Statistical Manual, Fourth Edition cri-
teria on a Likert-type scale, ranging from 0 (“not at all”)
to 3 (“nearly every day”). Total scores≥ 10 represent clin-
ically significant depressive symptoms and inter-test
score differences≥ 5 suggest clinically significant change
[27,28].
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The Problem Areas in Diabetes Scale (PAID) was used
to assess diabetes-specific emotional distress [29,30].
This 20-item scale measures the extent to which living
with and managing diabetes contributes to feelings of
emotional burden (e.g., guilt, frustration, anger, depres-
sion). Response options range from 0 (“not a problem”)
to 4 (“serious problem”). Scores are transformed on a
scale from 0 to 100, with higher scores reflecting greater
distress. Prior research suggests that a score of 50 or
greater indicates clinically significant diabetes-related
distress [31].
Results
Eight patients with a mean age of 62 years (range=58–
67) were enrolled in the program. Following enrollment,
an intervention coach was assigned. Intervention coa-
ches called their assigned participants within 5 days of
mailing the participant workbook to schedule their first
HOPE session.
The following results section will present clinical out-
come data from the HOPE trial followed by three case
study reports that provide additional information about
salient intervention concepts. All participant names have
been changed.
Quantitative data
Eight older individuals enrolled in HOPE, seven of
whom completed the program (one did not proceed be-
yond session 1 because of an unrelated hospital admis-
sion). Enrolled participants were, on average, 62 years of
age (range 58–67), had been living with diabetes for over
17 years, and lived over 30 miles from their primary care
provider (PCP). Over 70% of the participants had
received mental health treatment in the past, and over
85% were receiving insulin therapy. Table 2 contains a
full listing of participant demographic characteristics.
Clinical outcome data from this trial, including HbA1c,
PHQ-9, and diabetes distress scores pre- and post-Table 2 Baseline characteristics of the study population
Characteristics Value
Age in years,M (SD) 62.1 (2.85)
White race,n (%) 4 (57)
Male gender,n (%) 6 (86)
Body mass index (BMI),M (SD) 34.1 (6.47)
Years living with diabetes,M (SD) 17.4 (7.39)
Distance to PCP (in miles),M (SD), R 33.6 (17.6), 15-70
Prior mental health treatment,n (%) 5 (71)
Receiving depression treatment,n (%) 4 (57)
Receiving insulin therapy,n (%) 6 (86)
M Mean, SD Standard Deviation, R Range, n number of participants, PCP
Primary Care Provider.treatment, can be found in Table 3. Effect sizes using
Cohen's d (with pooled standard deviations) were found
for HbA1c at post-treatment (d=0.36) and 6-month
follow-up (d=0.28); PHQ-9 at post-treatment (d=1.48)
and 6-month follow-up (d=1.69); and PAID at post-
treatment (d=1.50) and 6-month follow-up (d=1.06).
Upon completion of the coaching sessions, exit inter-
views were conducted with each participant, rating items
on a 5-point Likert scale (0=not at all, 5=very helpful).
On average, participants’ responses to the following
items suggested strong acceptability of the HOPE pro-
gram: “Overall, how would you say the HOPE program
was in improving your quality of life?” (M=4.5,
SD=0.756); “Overall, how would you say the HOPE pro-
gram was in helping you to learn to manage your dia-
betes?” (M=4.625, SD=0.744); “Overall, how would you
say the HOPE program was in helping you to manage
stress, anxiety, and depression?” (M=3.375, SD=1.506);
and “Overall, how confident are you that you will con-
tinue to use the skills in the future?” (M=4.5, SD=0.535,
where 5=very confident).
Qualitative data (case study reports)
The narratives below introduce HOPE patients and illus-
trate coaches’ use of the 5 As model of coping within a
chronic illness framework including focused intervention
efforts related to goal setting and action planning.
Case 1: Brian
Case 1: Brian, age 63. Brian, a retired Veteran, reported
high diabetes interference in his daily life at baseline
interview. His HbA1c, which ranged from 8.9 to 11.3
over the last year (M=10.9, SD=1.19), was 11.2 at base-
line. He was also morbidly obese, suffered from sleep
apnea, and had been diagnosed with Major Depressive
Disorder, exemplified by his PHQ-9 baseline score of 13.
He acknowledged that his diet was poor and that he had
limited diabetes knowledge. Brian was admittedly doubt-
ful at the start of the intervention of HOPE’s potential
efficacy in producing positive health outcomes.
After assessing Brian’s diabetes knowledge and con-
cerns about the HOPE Program, his coach advised him
on goal-setting. Acknowledging his unstable HbA1c
markers, Brian agreed to set multiple diet goals, includ-
ing controlling meal portion sizes, increasing fruit and
vegetable intake, reducing carbohydrate intake, and
keeping a food log to monitor this goal for the duration
of the program. Brian was initially skeptical about the
process; however, as he began successfully reaching goal-
setting milestones, he became increasingly engaged in
the program. Brian experienced significant goal attain-
ment, consistently increasing the scope of his goals as he
progressed, and later adding fitness and medication-
Table 3 Clinical outcome data for the HOPE Pilot study cohort
Data-Collection Timeframe Outcome Measures
HbA1c PHQ-9 PAID
Baseline, M (SD) 9.73 (2.62) 14.6 (2.99) 46.8 (6.29)
3-month, M (SD) 8.60 (3.56) 9.43 (3.91) 28.9 (15.6)
Change from baseline to 3-month, M (SD) 1.13 (1.70) 5.14 (2.27) 17.7 (10.7)
Effect Size, Cohen’s d 0.36 1.48 1.50
6-month, M (SD) 8.89 (3.35) 7.57 (5.03) 26.9 (25.9)
Change from baseline to 6-month, M (SD) 0.84 (1.62) 7.03 (4.43) 20.4 (20.7)
Effect Size, Cohen’s d 0.28 1.69 1.06
M mean, SD standard deviation, R range;
Effect sizes measured using Cohen’s d (0.8=large effect, 0.5=medium effect, 0.2=small effect).
Baseline=readings at baseline assessment;
3-month=readings at 3-month follow-up assessment;
6-month=readings at 6-month follow-up assessment.
HbA1c hemoglobin A1c; Lower HbA1c is consistent with better diabetes control.
PHQ-9 Patient Health Questionnaire-9; Higher total PHQ-9 scores indicate elevated depressive symptoms.
PAID Problem Areas In Diabetes scale; Higher total PAID scores represent greater diabetes related distress.
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communication with his wife and increasing his diabetes
care self-efficacy, arranging a self-monitoring plan to
help maintain future success and communication action
plans with his PCP to help manage mild hypoglycemia
symptoms with improved control. Brian realized a
marked drop in HbA1c from 11.2 at baseline to 7.2 at 6-
month follow- up, and a reduction in diabetes distress
(PAID score improved 3.75 at 6-month follow-up).
Though his depression score at baseline (13) showed
clinically significant improvement at 3-month follow-up,
his depressive symptoms at 6-month follow-up returned
to baseline functioning, suggesting the need for add-
itional depression intervention.Case 2: Laura
Case 2: Laura, age 59 Laura was a disabled Veteran,
divorced, and living alone. She entered the HOPE pro-
gram with severely high HbA1c at baseline (14.8), shown
to be consistent over the past year (M=13.5, SD=2.15).
She disclosed that daily diabetes monitoring limited her
physical activity, causing stress and anxiety. In addition,
she suffered from multiple comorbidities, including
Major Depressive Disorder (demonstrated by her high
baseline PHQ-9 score of 19), post- traumatic stress dis-
order, and asthma. Prescribed an extensive list of medi-
cations, she admitted to having trouble adhering to her
complicated regimen because of side-effects, financial
limitations, and scheduling conflicts.
During her initial session, Laura expressed optimism
for the potential outcomes of HOPE, despite some initial
resistance to participate because of failures experienced
in a prior diabetes education program. On the basis of
Laura’s extremely high diabetes numbers, her coachadvised her to take immediate steps to alter lifestyle
choices; she agreed to begin walking for 30 minutes
daily, planning to increase scope and potency of this goal
as she progressed. She also committed to stop eating fast
food and began packing healthy snacks to carry through-
out her day. However, after completing her fourth ses-
sion, she experienced a stressful life event that caused
her to disengage from HOPE, and she began missing
and/or rescheduling coaching sessions. Given the signifi-
cant barriers to goal attainment, Laura and her coach
decided not to attempt any new goals. Her coach
attempted to assist her to overcome barriers to her ini-
tial goals. They used the remaining interactions to ar-
range a prolonged monitoring plan and, although Laura
verbally maintained commitment to finish the program,
she eventually completed only five sessions. Though she
reported improvements in diabetes distress at 3-month
follow-up (PAID score improved by 30) and depression
at 3-month follow-up (PHQ-9 score had significant im-
provement of 6 points), her HbA1c did not improve
(increase from 14.8 at baseline to 16.1 at 6-month
follow-up). By the conclusion of the pilot, her PCP had
ordered a more aggressive medical intervention; yet she
maintained her positive improvements related to depres-
sive symptoms and diabetes distress.Case 3: Daniel
Case 3: Daniel, age 62 Daniel was a disabled Veteran,
divorced, and living alone at the time of treatment initi-
ation. At baseline, he reported feeling stuck in daily rou-
tines (e.g. poor diet, lack of exercise) that he considered
unhealthy. He also reported problems falling and staying
asleep, which interfered with the daytime activities ne-
cessary to effectively manage his diabetes. His
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PHQ-9 (14) were likely a result of these factors. He felt a
great deal of stress and worry over potential complica-
tions of his condition, especially because several of his
family members had experienced diabetes-related com-
plications. Additionally, he found social situations that
involved eating to be difficult, given his dietary restric-
tions, and admitted to occasional interpersonal difficul-
ties caused by low frustration tolerance and poor stress
management.
In assessing Daniel, his coach recognized lifestyle pro-
blems common to uncontrolled diabetes and advised
that simple lifestyle modifications would make a big dif-
ference in overall well-being. The dyad agreed to begin
with a fitness goal of walking ¼ mile 5–6 days per week,
which Daniel successfully increased to 1 mile as he pro-
gressed through the program. In addition to addressing
physical goal barriers, such as pain from a leg injury that
caused sleep problems, Daniel’s coach assisted him by
helping him identify emotional concerns that could im-
pede goal attainment. Daniel became open to practicing
relaxation techniques during coaching sessions and
established a goal to incorporate them in his daily life. In
arranging for prolonged goal maintenance, his coach
emphasized the need to identify barriers to his goals and
encouraged him to share his diabetes experiences with
others to help improve his social connections. At the
conclusion of the treatment, Daniel realized notable 6-
month changes, including moderate yet clinically signifi-
cant improvement in HbA1c (drop of 0.9 from baseline)
and marked reductions in depression (PHQ-9 score
improved 14 points) and diabetes distress (PAID score
improved 37.5 points).
Discussion
The HOPE program is a structured, theory-driven psy-
chosocial intervention that uses telephone-based behav-
ioral health coaching to promote lifestyle changes for
improved diabetes control and reduced depressive symp-
toms in older rural-dwelling patients. Initial data from
the HOPE program suggest that the multifaceted inter-
vention, as designed, may generate positive outcomes for
both physical and emotional aspects of diabetes self-care.
Patient-level data and qualitative interviews post-
treatment suggest that patients responded positively to
the collaborative goal setting and action-planning
process. Prior diabetes and depression interventions have
typically shown positive outcomes for either diabetes or
depression markers, but not both [32-39]. Under these
more narrowed aims, structured behavioral intervention
strategies have been demonstrated to be more effective at
improving glycemic control than traditional diabetes
education programs in patients with diabetes for at least
two years [40]. In contrast, the HOPE programdemonstrated an ability to cultivate positive outcomes
across all clinically relevant measures, including diabetes-
related distress, in a group of medically complex patients
with an average diabetes duration of 17 years. Changes in
clinical outcomes may be related to reductions in
diabetes-related distress, measured by the validated PAID
instrument [41]. These findings, derived through the ap-
plication of a simple telephone-based protocol delivered
by non-expert coaches, extend the results seen in more
resource-intensive interventions targeting diabetes and
depression [42].
Common among the HOPE pilot cohort was the initial
selection of more traditional diabetes lifestyle goals (e.g.
diet and exercise), rather than emotional health goals.
On the whole, participants were initially reluctant to dis-
cuss topics related to emotional well-being, possibly be-
cause they did not want to appear vulnerable, or due to
lack of awareness and understanding of a potential con-
nection to self-management and physical health. Those
participants who did engage around affective goals were
usually encouraged to do so by their coaches when they
encountered goal barriers that could not be overcome
through physical health changes alone. It may have been
this private individualized attention from coaches and
the built-in process of building rapport that eventually
encouraged goal-setting around emotional health issues.
Prior research has shown individual education to be su-
perior over group education and usual care in reducing
HbA1c, further supporting this notion [43]. Importantly,
outcome data from the trial suggest that, although emo-
tional health concerns were not always addressed
overtly, especially at the onset of treatment, depressive
symptoms may be reduced, as evidenced by the 6-month
effect size for PHQ-9 scores (d=1.70).
Participants were also generally hesitant to discuss
their diabetes medication regimens including associated
side-effects, unless hypoglycemia-related issues arose
during the program. If this happened, coaches helped
participants to identify and monitor hypoglycemia-
related events and construct action plans with PCPs to
address this potentially dangerous side-effect. Thus, the
HOPE program may be an effective method of addres-
sing hypoglycemia-related events that arise during dia-
betes interventions.
The pilot cohort completion rate indicated high pa-
tient acceptability and satisfaction with the HOPE inter-
vention. HOPE holds the potential to be implemented in
clinical practice and the use of non-experts as coaches
may reduce potential "translational" difficulties including
limited mental health provider availability and other
time and resource limitations common to the use of be-
havioral change interventions. HOPE may be especially
suitable for older adults with multiple chronic condi-
tions. The telephone-based nature of the program
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individuals who may be unable or unwilling to travel to
and from a central treatment site due to functional lim-
itations or a lack of social support [44]. Importantly,
HOPE was structured to support and sustain aging in
place initiatives that promote independent living among
older adults. The HOPE protocol also fosters self-
efficacy with chronic self-management by encouraging,
supporting, and providing practice for participants to
engage in proactive coping and skill development efforts
that initiate and sustain behavioral change. Coping skills
prevent and alleviate stress allowing older adults to pre-
serve resources that are susceptible to aging-related
losses and declines [45]. Previous research also high-
lights the importance of perceived control as a key com-
ponent of successful aging [46,47]. Our study
corroborates previous research [48] suggesting that
middle-aged and older adults can learn, integrate, and
practice proactive coping skills. Using these skills, it
appears that the rural-dwelling adults in our study were
able to take charge of their own health and better pos-
ition themselves for future health challenges.
Limitations and future research
A number of limitations in the present study should be
acknowledged. While participants in the HOPE trial rea-
lized notable positive clinical changes, the small sample
size and lack of control group limit the generalizability
and interpretation of study clinical outcomes. Although
effect sizes were maintained at 6-months, time constraints
to complete the pilot did not allow for longer-term follow-
up sessions to promote maintenance of goal attainment. A
larger trial could allow for a more comprehensive examin-
ation of the HOPE intervention using a larger sample size,
intervention control group, and lengthier follow-up to
evaluate long-term self-management behaviors.
It is important to note that the age cohort (range=58–
67) of our pilot participants may have led to greater
intervention acceptability and better clinical outcomes
than would be realized with an older age group. How-
ever, due to the complexity and severity of conditions
experienced by this cohort at baseline, our results show
promise for the potential of clinical improvements in
others treated within the HOPE program.
Lastly, we did not seek direct PCP engagement in the
treatment process, although coaches did communicate
goal progress through passive notes in patients’ electronic
medical records and were aware of PCPs’ treatment plans
as documented in medical records. Increased interface
with participants’ PCPs above the standard chart notes
could increase provider engagement and may have helped
guide tailored intervention plans for each patient poten-
tially further personalizing treatment. We acknowledge
there are potential difficulties inherent in engagingclinicians, particularly clinician availability and willingness
to participate. Future work should focus on developing a
system that would further facilitate sharing of information
between PCPs and HOPE coaches.
Experiences from the HOPE open pilot suggest that
patients with severe depressive symptoms and/or long-
standing mental health issues, such as Major Depressive
Disorder or post-traumatic stress disorder, may be poor
candidates for HOPE, as they require mental health
treatment beyond the scope of this intervention. Future
studies should examine the association between severity
of depression and other mental health comorbidities in
response to treatment and potential need for a stepped-
care approach.
Conclusion
Overall, HOPE demonstrated clinically meaningful
improvements in diabetes control, depressive symptoms,
and diabetes distress over a 6-month period, using a
tele-coaching intervention. HOPE appears to be a feas-
ible and potentially cost-effective, telephone-delivered
coaching intervention targeting high-risk older patients
with comorbid diabetes and depression. Because older
adults experience increased obstacles (e.g. financial lim-
itations; lack of transportation/inability to self-transport;
comorbid/unrelated health conditions restricting mobil-
ity) to participation in clinic-based diabetes protocols,
HOPE may provide a viable option to reach geographic-
ally isolated or disparate populations with limited access
to comprehensive diabetes and mental health care.
While HOPE cannot replace the need for basic primary
care, it does provide a potentially critical adjunct for
aging patients with treated but uncontrolled diabetes
and depression. A larger study with lengthier follow-up
and greater PCP engagement is needed to support and
extend the findings of this pilot.
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